XML 45 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Loans Receivable (Tables) - Loans receivable
9 Months Ended
Sep. 30, 2017
Loans Receivable:  
Schedule of Loans Receivable
The following table summarizes the Company’s loans receivable (in thousands):
 
September 30, 2017
 
December 31, 2016
 
Real Estate
Secured
 
Other
Secured
 
Total
 
Real Estate
Secured
 
Other
Secured
 
Total
Mezzanine(1)
$

 
$
277,299

 
$
277,299

 
$

 
$
615,188

 
$
615,188

Other(2)
184,880

 

 
184,880

 
195,946

 

 
195,946

Unamortized discounts, fees and costs(1)

 
(607
)
 
(607
)
 
413

 
(3,593
)
 
(3,180
)
Allowance for loan losses(3)

 
(59,420
)
 
(59,420
)
 

 

 

 
$
184,880

 
$
217,272

 
$
402,152

 
$
196,359

 
$
611,595

 
$
807,954

_______________________________________
(1)
At December 31, 2016, included £282 million ($348 million) outstanding and £2 million ($3 million) of associated unamortized discounts, fees and costs, both related to the HC-One Facility, which paid off in June 2017.
(2)
At September 30, 2017 and December 31, 2016, included £122 million ($163 million) and £113 million ($140 million), respectively, outstanding primarily related to Maria Mallaband loans.
(3)
Related to the Company’s mezzanine loan facility to Tandem Health Care discussed below.
Summary of the Company's Internal Ratings for Loans Receivable
The following table summarizes the Company’s internal ratings for loans receivable at September 30, 2017 (dollars in thousands):
 
 
Carrying
Amount
 
Percentage of
Loan Portfolio
 
Internal Ratings
Investment Type
 
 
 
Performing Loans
 
Watch List Loans
 
Workout Loans
Real estate secured
 
$
184,880

 
46%
 
$
184,880

 
$

 
$

Other secured
 
217,272

 
54
 
19,898

 

 
197,374


 
$
402,152

 
100%
 
$
204,778

 
$

 
$
197,374